Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Billiontoone Inc Cl A (BLLN)

Billiontoone Inc Cl A (BLLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,386,906
  • Shares Outstanding, K 45,769
  • Annual Sales, $ 305,110 K
  • Annual Income, $ 7,450 K
  • EBIT $ -3 M
  • EBITDA $ 28 M
  • 60-Month Beta N/A
  • Price/Sales 10.69
  • Price/Cash Flow 220.01
  • Price/Book 6.79

Options Overview Details

View History
  • Implied Volatility 82.98% (+5.90%)
  • Historical Volatility 84.77%
  • IV Percentile 19%
  • IV Rank 20.96%
  • IV High 105.24% on 02/27/26
  • IV Low 77.08% on 03/19/26
  • Expected Move (DTE 28) 13.01 (17.11%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 9
  • Volume Avg (30-Day) 45
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 479
  • Open Int (30-Day) 264
  • Expected Range 63.00 to 89.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.01
  • Number of Estimates 4
  • High Estimate 0.06
  • Low Estimate -0.03
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.96 +22.66%
on 03/12/26
86.01 -11.64%
on 03/05/26
-9.42 (-11.03%)
since 02/20/26
3-Month
61.96 +22.66%
on 03/12/26
103.60 -26.64%
on 12/22/25
-26.60 (-25.93%)
since 12/19/25

Most Recent Stories

More News
BillionToOne: Q4 Earnings Snapshot

BillionToOne: Q4 Earnings Snapshot

BLLN : 76.00 (+2.70%)
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 76.00 (+2.70%)
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

MENLO PARK, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 76.00 (+2.70%)
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®

Northstar PGx™ and Northstar Select CH™ extend clinical insight and utility of Northstar Select ® all from the same blood-draw

BLLN : 76.00 (+2.70%)
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care

BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen Testing to Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

BLLN : 76.00 (+2.70%)
BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare

Integration enables seamless ordering and results delivery within Epic for UNITY Complete® and Northstar® tests, creating a better patient and provider experience

BLLN : 76.00 (+2.70%)
BillionToOne Provides Guidance for 2026

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 76.00 (+2.70%)
BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

Ultra-sensitive liquid biopsy is expanding precision medicine access for patients in Japan with treatment-resistant non-small cell lung cancer (NSCLC)

BLLN : 76.00 (+2.70%)
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 76.00 (+2.70%)
BillionToOne Reports Third Quarter 2025 Results

MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

BLLN : 76.00 (+2.70%)

Business Summary

BillionToOne Inc. is a molecular diagnostics company. BillionToOne Inc. is based in headquartered in Menlo Park, California.

See More

Key Turning Points

3rd Resistance Point 81.33
2nd Resistance Point 78.90
1st Resistance Point 77.45
Last Price 76.00
1st Support Level 73.57
2nd Support Level 71.14
3rd Support Level 69.69

See More

52-Week High 138.70
Fibonacci 61.8% 109.39
Fibonacci 50% 100.33
Fibonacci 38.2% 91.27
Last Price 76.00
52-Week Low 61.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.